
Prof. Dr. Simone Moser holds a degree in Chemistry from the University of Innsbruck, where she completed her PhD focusing on the isolation and structural characterization of natural compounds. Her postdoctoral research at the École Polytechnique Fédérale de Lausanne (EPFL) and the Massachusetts Institute of Technology (MIT) centered on elucidating the modes of action of small molecules.
Following her postdoctoral studies, Dr. Moser joined the Analytical Development team at Novartis in Austria. She later returned to academia, establishing her research group within the Chair of Pharmaceutical Biology at the Ludwig Maximilian University of Munich (LMU), where she completed her habilitation in 2022.
In September 2023, Dr. Moser was appointed Head of the Department of Pharmacognosy at the University of Innsbruck, Austria. Her research on the pharmaceutical properties of newly discovered natural products has earned her several prestigious awards, including the Blair-Curtius-Pfleiderer-Wachter Prize for Pteridinology (2020) and the Dr. Willmar Schwabe Prize from the Society for Medicinal Plant and Natural Product Research (2022).